Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated cord blood transplantation with mesenchymal stromal cell co-infusion in severe generalized recessive dystrophic epidermolysis bullosa
2012-000605-72Phase 2Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2013
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Provacel in epidermolysis bullosa (EB), sponsored by University Medical Center Utrecht. Primary endpoints: Safety of unrelated cord blood transplantation with mesenchymal stromal cell co-infusion and Sustained full cord blood donor chimerism. Started Aug 2013; status: terminated.
02
Drugs
Provacel
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on 2012-000605-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000605-72.